Global TB Disease Vaccine Market Research Report 2023(Status and Outlook)
Report Overview
The vaccine for tuberculosis (TB) is known as BCG (bacille Calmette-Gu?rin) vaccine. BCG vaccine contains a weakened form of the bacteria (germ) that cause TB. Because it is weakened it doesn't cause TB in healthy people but it helps develop some protection (immunity) against TB.
Bosson Research’s latest report provides a deep insight into the global TB Disease Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global TB Disease Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the TB Disease Vaccine market in any manner.
Global TB Disease Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC
Queen Saovabha Mem. Inst
Microgen
Market Segmentation (by Type)
Prevention Vaccines
Post-exposure Vaccines
Others
Market Segmentation (by Application)
Self-Procurement
UNICEF
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the TB Disease Vaccine Market
Overview of the regional outlook of the TB Disease Vaccine Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the TB Disease Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
The vaccine for tuberculosis (TB) is known as BCG (bacille Calmette-Gu?rin) vaccine. BCG vaccine contains a weakened form of the bacteria (germ) that cause TB. Because it is weakened it doesn't cause TB in healthy people but it helps develop some protection (immunity) against TB.
Bosson Research’s latest report provides a deep insight into the global TB Disease Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global TB Disease Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the TB Disease Vaccine market in any manner.
Global TB Disease Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC
Queen Saovabha Mem. Inst
Microgen
Market Segmentation (by Type)
Prevention Vaccines
Post-exposure Vaccines
Others
Market Segmentation (by Application)
Self-Procurement
UNICEF
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the TB Disease Vaccine Market
Overview of the regional outlook of the TB Disease Vaccine Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the TB Disease Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of TB Disease Vaccine
1.2 Key Market Segments
1.2.1 TB Disease Vaccine Segment by Type
1.2.2 TB Disease Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 TB DISEASE VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global TB Disease Vaccine Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global TB Disease Vaccine Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 TB DISEASE VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global TB Disease Vaccine Sales by Manufacturers (2018-2023)
3.2 Global TB Disease Vaccine Revenue Market Share by Manufacturers (2018-2023)
3.3 TB Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global TB Disease Vaccine Average Price by Manufacturers (2018-2023)
3.5 Manufacturers TB Disease Vaccine Sales Sites, Area Served, Product Type
3.6 TB Disease Vaccine Market Competitive Situation and Trends
3.6.1 TB Disease Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest TB Disease Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 TB DISEASE VACCINE INDUSTRY CHAIN ANALYSIS
4.1 TB Disease Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF TB DISEASE VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 TB DISEASE VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global TB Disease Vaccine Sales Market Share by Type (2018-2023)
6.3 Global TB Disease Vaccine Market Size Market Share by Type (2018-2023)
6.4 Global TB Disease Vaccine Price by Type (2018-2023)
7 TB DISEASE VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global TB Disease Vaccine Market Sales by Application (2018-2023)
7.3 Global TB Disease Vaccine Market Size (M USD) by Application (2018-2023)
7.4 Global TB Disease Vaccine Sales Growth Rate by Application (2018-2023)
8 TB DISEASE VACCINE MARKET SEGMENTATION BY REGION
8.1 Global TB Disease Vaccine Sales by Region
8.1.1 Global TB Disease Vaccine Sales by Region
8.1.2 Global TB Disease Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America TB Disease Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe TB Disease Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific TB Disease Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America TB Disease Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa TB Disease Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Merck
9.1.1 Merck TB Disease Vaccine Basic Information
9.1.2 Merck TB Disease Vaccine Product Overview
9.1.3 Merck TB Disease Vaccine Product Market Performance
9.1.4 Merck Business Overview
9.1.5 Merck TB Disease Vaccine SWOT Analysis
9.1.6 Merck Recent Developments
9.2 Japan BCG Lab
9.2.1 Japan BCG Lab TB Disease Vaccine Basic Information
9.2.2 Japan BCG Lab TB Disease Vaccine Product Overview
9.2.3 Japan BCG Lab TB Disease Vaccine Product Market Performance
9.2.4 Japan BCG Lab Business Overview
9.2.5 Japan BCG Lab TB Disease Vaccine SWOT Analysis
9.2.6 Japan BCG Lab Recent Developments
9.3 Serum Institute of India
9.3.1 Serum Institute of India TB Disease Vaccine Basic Information
9.3.2 Serum Institute of India TB Disease Vaccine Product Overview
9.3.3 Serum Institute of India TB Disease Vaccine Product Market Performance
9.3.4 Serum Institute of India Business Overview
9.3.5 Serum Institute of India TB Disease Vaccine SWOT Analysis
9.3.6 Serum Institute of India Recent Developments
9.4 AJ Vaccines
9.4.1 AJ Vaccines TB Disease Vaccine Basic Information
9.4.2 AJ Vaccines TB Disease Vaccine Product Overview
9.4.3 AJ Vaccines TB Disease Vaccine Product Market Performance
9.4.4 AJ Vaccines Business Overview
9.4.5 AJ Vaccines TB Disease Vaccine SWOT Analysis
9.4.6 AJ Vaccines Recent Developments
9.5 BioFarma
9.5.1 BioFarma TB Disease Vaccine Basic Information
9.5.2 BioFarma TB Disease Vaccine Product Overview
9.5.3 BioFarma TB Disease Vaccine Product Market Performance
9.5.4 BioFarma Business Overview
9.5.5 BioFarma TB Disease Vaccine SWOT Analysis
9.5.6 BioFarma Recent Developments
9.6 GreenSignal Bio Pharma
9.6.1 GreenSignal Bio Pharma TB Disease Vaccine Basic Information
9.6.2 GreenSignal Bio Pharma TB Disease Vaccine Product Overview
9.6.3 GreenSignal Bio Pharma TB Disease Vaccine Product Market Performance
9.6.4 GreenSignal Bio Pharma Business Overview
9.6.5 GreenSignal Bio Pharma Recent Developments
9.7 China National Biotec
9.7.1 China National Biotec TB Disease Vaccine Basic Information
9.7.2 China National Biotec TB Disease Vaccine Product Overview
9.7.3 China National Biotec TB Disease Vaccine Product Market Performance
9.7.4 China National Biotec Business Overview
9.7.5 China National Biotec Recent Developments
9.8 Biomed Lublin
9.8.1 Biomed Lublin TB Disease Vaccine Basic Information
9.8.2 Biomed Lublin TB Disease Vaccine Product Overview
9.8.3 Biomed Lublin TB Disease Vaccine Product Market Performance
9.8.4 Biomed Lublin Business Overview
9.8.5 Biomed Lublin Recent Developments
9.9 Taj Pharmaceuticals
9.9.1 Taj Pharmaceuticals TB Disease Vaccine Basic Information
9.9.2 Taj Pharmaceuticals TB Disease Vaccine Product Overview
9.9.3 Taj Pharmaceuticals TB Disease Vaccine Product Market Performance
9.9.4 Taj Pharmaceuticals Business Overview
9.9.5 Taj Pharmaceuticals Recent Developments
9.10 Ataulpho de Paiva
9.10.1 Ataulpho de Paiva TB Disease Vaccine Basic Information
9.10.2 Ataulpho de Paiva TB Disease Vaccine Product Overview
9.10.3 Ataulpho de Paiva TB Disease Vaccine Product Market Performance
9.10.4 Ataulpho de Paiva Business Overview
9.10.5 Ataulpho de Paiva Recent Developments
9.11 IVAC
9.11.1 IVAC TB Disease Vaccine Basic Information
9.11.2 IVAC TB Disease Vaccine Product Overview
9.11.3 IVAC TB Disease Vaccine Product Market Performance
9.11.4 IVAC Business Overview
9.11.5 IVAC Recent Developments
9.12 Queen Saovabha Mem. Inst
9.12.1 Queen Saovabha Mem. Inst TB Disease Vaccine Basic Information
9.12.2 Queen Saovabha Mem. Inst TB Disease Vaccine Product Overview
9.12.3 Queen Saovabha Mem. Inst TB Disease Vaccine Product Market Performance
9.12.4 Queen Saovabha Mem. Inst Business Overview
9.12.5 Queen Saovabha Mem. Inst Recent Developments
9.13 Microgen
9.13.1 Microgen TB Disease Vaccine Basic Information
9.13.2 Microgen TB Disease Vaccine Product Overview
9.13.3 Microgen TB Disease Vaccine Product Market Performance
9.13.4 Microgen Business Overview
9.13.5 Microgen Recent Developments
10 TB DISEASE VACCINE MARKET FORECAST BY REGION
10.1 Global TB Disease Vaccine Market Size Forecast
10.2 Global TB Disease Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe TB Disease Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific TB Disease Vaccine Market Size Forecast by Region
10.2.4 South America TB Disease Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of TB Disease Vaccine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2024-2029)
11.1 Global TB Disease Vaccine Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of TB Disease Vaccine by Type (2024-2029)
11.1.2 Global TB Disease Vaccine Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of TB Disease Vaccine by Type (2024-2029)
11.2 Global TB Disease Vaccine Market Forecast by Application (2024-2029)
11.2.1 Global TB Disease Vaccine Sales (K MT) Forecast by Application
11.2.2 Global TB Disease Vaccine Market Size (M USD) Forecast by Application (2024-2029)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of TB Disease Vaccine
1.2 Key Market Segments
1.2.1 TB Disease Vaccine Segment by Type
1.2.2 TB Disease Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 TB DISEASE VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global TB Disease Vaccine Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global TB Disease Vaccine Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 TB DISEASE VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global TB Disease Vaccine Sales by Manufacturers (2018-2023)
3.2 Global TB Disease Vaccine Revenue Market Share by Manufacturers (2018-2023)
3.3 TB Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global TB Disease Vaccine Average Price by Manufacturers (2018-2023)
3.5 Manufacturers TB Disease Vaccine Sales Sites, Area Served, Product Type
3.6 TB Disease Vaccine Market Competitive Situation and Trends
3.6.1 TB Disease Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest TB Disease Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 TB DISEASE VACCINE INDUSTRY CHAIN ANALYSIS
4.1 TB Disease Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF TB DISEASE VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 TB DISEASE VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global TB Disease Vaccine Sales Market Share by Type (2018-2023)
6.3 Global TB Disease Vaccine Market Size Market Share by Type (2018-2023)
6.4 Global TB Disease Vaccine Price by Type (2018-2023)
7 TB DISEASE VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global TB Disease Vaccine Market Sales by Application (2018-2023)
7.3 Global TB Disease Vaccine Market Size (M USD) by Application (2018-2023)
7.4 Global TB Disease Vaccine Sales Growth Rate by Application (2018-2023)
8 TB DISEASE VACCINE MARKET SEGMENTATION BY REGION
8.1 Global TB Disease Vaccine Sales by Region
8.1.1 Global TB Disease Vaccine Sales by Region
8.1.2 Global TB Disease Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America TB Disease Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe TB Disease Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific TB Disease Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America TB Disease Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa TB Disease Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Merck
9.1.1 Merck TB Disease Vaccine Basic Information
9.1.2 Merck TB Disease Vaccine Product Overview
9.1.3 Merck TB Disease Vaccine Product Market Performance
9.1.4 Merck Business Overview
9.1.5 Merck TB Disease Vaccine SWOT Analysis
9.1.6 Merck Recent Developments
9.2 Japan BCG Lab
9.2.1 Japan BCG Lab TB Disease Vaccine Basic Information
9.2.2 Japan BCG Lab TB Disease Vaccine Product Overview
9.2.3 Japan BCG Lab TB Disease Vaccine Product Market Performance
9.2.4 Japan BCG Lab Business Overview
9.2.5 Japan BCG Lab TB Disease Vaccine SWOT Analysis
9.2.6 Japan BCG Lab Recent Developments
9.3 Serum Institute of India
9.3.1 Serum Institute of India TB Disease Vaccine Basic Information
9.3.2 Serum Institute of India TB Disease Vaccine Product Overview
9.3.3 Serum Institute of India TB Disease Vaccine Product Market Performance
9.3.4 Serum Institute of India Business Overview
9.3.5 Serum Institute of India TB Disease Vaccine SWOT Analysis
9.3.6 Serum Institute of India Recent Developments
9.4 AJ Vaccines
9.4.1 AJ Vaccines TB Disease Vaccine Basic Information
9.4.2 AJ Vaccines TB Disease Vaccine Product Overview
9.4.3 AJ Vaccines TB Disease Vaccine Product Market Performance
9.4.4 AJ Vaccines Business Overview
9.4.5 AJ Vaccines TB Disease Vaccine SWOT Analysis
9.4.6 AJ Vaccines Recent Developments
9.5 BioFarma
9.5.1 BioFarma TB Disease Vaccine Basic Information
9.5.2 BioFarma TB Disease Vaccine Product Overview
9.5.3 BioFarma TB Disease Vaccine Product Market Performance
9.5.4 BioFarma Business Overview
9.5.5 BioFarma TB Disease Vaccine SWOT Analysis
9.5.6 BioFarma Recent Developments
9.6 GreenSignal Bio Pharma
9.6.1 GreenSignal Bio Pharma TB Disease Vaccine Basic Information
9.6.2 GreenSignal Bio Pharma TB Disease Vaccine Product Overview
9.6.3 GreenSignal Bio Pharma TB Disease Vaccine Product Market Performance
9.6.4 GreenSignal Bio Pharma Business Overview
9.6.5 GreenSignal Bio Pharma Recent Developments
9.7 China National Biotec
9.7.1 China National Biotec TB Disease Vaccine Basic Information
9.7.2 China National Biotec TB Disease Vaccine Product Overview
9.7.3 China National Biotec TB Disease Vaccine Product Market Performance
9.7.4 China National Biotec Business Overview
9.7.5 China National Biotec Recent Developments
9.8 Biomed Lublin
9.8.1 Biomed Lublin TB Disease Vaccine Basic Information
9.8.2 Biomed Lublin TB Disease Vaccine Product Overview
9.8.3 Biomed Lublin TB Disease Vaccine Product Market Performance
9.8.4 Biomed Lublin Business Overview
9.8.5 Biomed Lublin Recent Developments
9.9 Taj Pharmaceuticals
9.9.1 Taj Pharmaceuticals TB Disease Vaccine Basic Information
9.9.2 Taj Pharmaceuticals TB Disease Vaccine Product Overview
9.9.3 Taj Pharmaceuticals TB Disease Vaccine Product Market Performance
9.9.4 Taj Pharmaceuticals Business Overview
9.9.5 Taj Pharmaceuticals Recent Developments
9.10 Ataulpho de Paiva
9.10.1 Ataulpho de Paiva TB Disease Vaccine Basic Information
9.10.2 Ataulpho de Paiva TB Disease Vaccine Product Overview
9.10.3 Ataulpho de Paiva TB Disease Vaccine Product Market Performance
9.10.4 Ataulpho de Paiva Business Overview
9.10.5 Ataulpho de Paiva Recent Developments
9.11 IVAC
9.11.1 IVAC TB Disease Vaccine Basic Information
9.11.2 IVAC TB Disease Vaccine Product Overview
9.11.3 IVAC TB Disease Vaccine Product Market Performance
9.11.4 IVAC Business Overview
9.11.5 IVAC Recent Developments
9.12 Queen Saovabha Mem. Inst
9.12.1 Queen Saovabha Mem. Inst TB Disease Vaccine Basic Information
9.12.2 Queen Saovabha Mem. Inst TB Disease Vaccine Product Overview
9.12.3 Queen Saovabha Mem. Inst TB Disease Vaccine Product Market Performance
9.12.4 Queen Saovabha Mem. Inst Business Overview
9.12.5 Queen Saovabha Mem. Inst Recent Developments
9.13 Microgen
9.13.1 Microgen TB Disease Vaccine Basic Information
9.13.2 Microgen TB Disease Vaccine Product Overview
9.13.3 Microgen TB Disease Vaccine Product Market Performance
9.13.4 Microgen Business Overview
9.13.5 Microgen Recent Developments
10 TB DISEASE VACCINE MARKET FORECAST BY REGION
10.1 Global TB Disease Vaccine Market Size Forecast
10.2 Global TB Disease Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe TB Disease Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific TB Disease Vaccine Market Size Forecast by Region
10.2.4 South America TB Disease Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of TB Disease Vaccine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2024-2029)
11.1 Global TB Disease Vaccine Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of TB Disease Vaccine by Type (2024-2029)
11.1.2 Global TB Disease Vaccine Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of TB Disease Vaccine by Type (2024-2029)
11.2 Global TB Disease Vaccine Market Forecast by Application (2024-2029)
11.2.1 Global TB Disease Vaccine Sales (K MT) Forecast by Application
11.2.2 Global TB Disease Vaccine Market Size (M USD) Forecast by Application (2024-2029)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. TB Disease Vaccine Market Size Comparison by Region (M USD)
Table 5. Global TB Disease Vaccine Sales (K MT) by Manufacturers (2018-2023)
Table 6. Global TB Disease Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 7. Global TB Disease Vaccine Revenue (M USD) by Manufacturers (2018-2023)
Table 8. Global TB Disease Vaccine Revenue Share by Manufacturers (2018-2023)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TB Disease Vaccine as of 2022)
Table 10. Global Market TB Disease Vaccine Average Price (USD/MT) of Key Manufacturers (2018-2023)
Table 11. Manufacturers TB Disease Vaccine Sales Sites and Area Served
Table 12. Manufacturers TB Disease Vaccine Product Type
Table 13. Global TB Disease Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of TB Disease Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. TB Disease Vaccine Market Challenges
Table 22. Market Restraints
Table 23. Global TB Disease Vaccine Sales by Type (K MT)
Table 24. Global TB Disease Vaccine Market Size by Type (M USD)
Table 25. Global TB Disease Vaccine Sales (K MT) by Type (2018-2023)
Table 26. Global TB Disease Vaccine Sales Market Share by Type (2018-2023)
Table 27. Global TB Disease Vaccine Market Size (M USD) by Type (2018-2023)
Table 28. Global TB Disease Vaccine Market Size Share by Type (2018-2023)
Table 29. Global TB Disease Vaccine Price (USD/MT) by Type (2018-2023)
Table 30. Global TB Disease Vaccine Sales (K MT) by Application
Table 31. Global TB Disease Vaccine Market Size by Application
Table 32. Global TB Disease Vaccine Sales by Application (2018-2023) & (K MT)
Table 33. Global TB Disease Vaccine Sales Market Share by Application (2018-2023)
Table 34. Global TB Disease Vaccine Sales by Application (2018-2023) & (M USD)
Table 35. Global TB Disease Vaccine Market Share by Application (2018-2023)
Table 36. Global TB Disease Vaccine Sales Growth Rate by Application (2018-2023)
Table 37. Global TB Disease Vaccine Sales by Region (2018-2023) & (K MT)
Table 38. Global TB Disease Vaccine Sales Market Share by Region (2018-2023)
Table 39. North America TB Disease Vaccine Sales by Country (2018-2023) & (K MT)
Table 40. Europe TB Disease Vaccine Sales by Country (2018-2023) & (K MT)
Table 41. Asia Pacific TB Disease Vaccine Sales by Region (2018-2023) & (K MT)
Table 42. South America TB Disease Vaccine Sales by Country (2018-2023) & (K MT)
Table 43. Middle East and Africa TB Disease Vaccine Sales by Region (2018-2023) & (K MT)
Table 44. Merck TB Disease Vaccine Basic Information
Table 45. Merck TB Disease Vaccine Product Overview
Table 46. Merck TB Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 47. Merck Business Overview
Table 48. Merck TB Disease Vaccine SWOT Analysis
Table 49. Merck Recent Developments
Table 50. Japan BCG Lab TB Disease Vaccine Basic Information
Table 51. Japan BCG Lab TB Disease Vaccine Product Overview
Table 52. Japan BCG Lab TB Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 53. Japan BCG Lab Business Overview
Table 54. Japan BCG Lab TB Disease Vaccine SWOT Analysis
Table 55. Japan BCG Lab Recent Developments
Table 56. Serum Institute of India TB Disease Vaccine Basic Information
Table 57. Serum Institute of India TB Disease Vaccine Product Overview
Table 58. Serum Institute of India TB Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 59. Serum Institute of India Business Overview
Table 60. Serum Institute of India TB Disease Vaccine SWOT Analysis
Table 61. Serum Institute of India Recent Developments
Table 62. AJ Vaccines TB Disease Vaccine Basic Information
Table 63. AJ Vaccines TB Disease Vaccine Product Overview
Table 64. AJ Vaccines TB Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 65. AJ Vaccines Business Overview
Table 66. AJ Vaccines TB Disease Vaccine SWOT Analysis
Table 67. AJ Vaccines Recent Developments
Table 68. BioFarma TB Disease Vaccine Basic Information
Table 69. BioFarma TB Disease Vaccine Product Overview
Table 70. BioFarma TB Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 71. BioFarma Business Overview
Table 72. BioFarma TB Disease Vaccine SWOT Analysis
Table 73. BioFarma Recent Developments
Table 74. GreenSignal Bio Pharma TB Disease Vaccine Basic Information
Table 75. GreenSignal Bio Pharma TB Disease Vaccine Product Overview
Table 76. GreenSignal Bio Pharma TB Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 77. GreenSignal Bio Pharma Business Overview
Table 78. GreenSignal Bio Pharma Recent Developments
Table 79. China National Biotec TB Disease Vaccine Basic Information
Table 80. China National Biotec TB Disease Vaccine Product Overview
Table 81. China National Biotec TB Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 82. China National Biotec Business Overview
Table 83. China National Biotec Recent Developments
Table 84. Biomed Lublin TB Disease Vaccine Basic Information
Table 85. Biomed Lublin TB Disease Vaccine Product Overview
Table 86. Biomed Lublin TB Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 87. Biomed Lublin Business Overview
Table 88. Biomed Lublin Recent Developments
Table 89. Taj Pharmaceuticals TB Disease Vaccine Basic Information
Table 90. Taj Pharmaceuticals TB Disease Vaccine Product Overview
Table 91. Taj Pharmaceuticals TB Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 92. Taj Pharmaceuticals Business Overview
Table 93. Taj Pharmaceuticals Recent Developments
Table 94. Ataulpho de Paiva TB Disease Vaccine Basic Information
Table 95. Ataulpho de Paiva TB Disease Vaccine Product Overview
Table 96. Ataulpho de Paiva TB Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 97. Ataulpho de Paiva Business Overview
Table 98. Ataulpho de Paiva Recent Developments
Table 99. IVAC TB Disease Vaccine Basic Information
Table 100. IVAC TB Disease Vaccine Product Overview
Table 101. IVAC TB Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 102. IVAC Business Overview
Table 103. IVAC Recent Developments
Table 104. Queen Saovabha Mem. Inst TB Disease Vaccine Basic Information
Table 105. Queen Saovabha Mem. Inst TB Disease Vaccine Product Overview
Table 106. Queen Saovabha Mem. Inst TB Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 107. Queen Saovabha Mem. Inst Business Overview
Table 108. Queen Saovabha Mem. Inst Recent Developments
Table 109. Microgen TB Disease Vaccine Basic Information
Table 110. Microgen TB Disease Vaccine Product Overview
Table 111. Microgen TB Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 112. Microgen Business Overview
Table 113. Microgen Recent Developments
Table 114. Global TB Disease Vaccine Sales Forecast by Region (2024-2029) & (K MT)
Table 115. Global TB Disease Vaccine Market Size Forecast by Region (2024-2029) & (M USD)
Table 116. North America TB Disease Vaccine Sales Forecast by Country (2024-2029) & (K MT)
Table 117. North America TB Disease Vaccine Market Size Forecast by Country (2024-2029) & (M USD)
Table 118. Europe TB Disease Vaccine Sales Forecast by Country (2024-2029) & (K MT)
Table 119. Europe TB Disease Vaccine Market Size Forecast by Country (2024-2029) & (M USD)
Table 120. Asia Pacific TB Disease Vaccine Sales Forecast by Region (2024-2029) & (K MT)
Table 121. Asia Pacific TB Disease Vaccine Market Size Forecast by Region (2024-2029) & (M USD)
Table 122. South America TB Disease Vaccine Sales Forecast by Country (2024-2029) & (K MT)
Table 123. South America TB Disease Vaccine Market Size Forecast by Country (2024-2029) & (M USD)
Table 124. Middle East and Africa TB Disease Vaccine Consumption Forecast by Country (2024-2029) & (Units)
Table 125. Middle East and Africa TB Disease Vaccine Market Size Forecast by Country (2024-2029) & (M USD)
Table 126. Global TB Disease Vaccine Sales Forecast by Type (2024-2029) & (K MT)
Table 127. Global TB Disease Vaccine Market Size Forecast by Type (2024-2029) & (M USD)
Table 128. Global TB Disease Vaccine Price Forecast by Type (2024-2029) & (USD/MT)
Table 129. Global TB Disease Vaccine Sales (K MT) Forecast by Application (2024-2029)
Table 130. Global TB Disease Vaccine Market Size Forecast by Application (2024-2029) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. TB Disease Vaccine Market Size Comparison by Region (M USD)
Table 5. Global TB Disease Vaccine Sales (K MT) by Manufacturers (2018-2023)
Table 6. Global TB Disease Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 7. Global TB Disease Vaccine Revenue (M USD) by Manufacturers (2018-2023)
Table 8. Global TB Disease Vaccine Revenue Share by Manufacturers (2018-2023)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TB Disease Vaccine as of 2022)
Table 10. Global Market TB Disease Vaccine Average Price (USD/MT) of Key Manufacturers (2018-2023)
Table 11. Manufacturers TB Disease Vaccine Sales Sites and Area Served
Table 12. Manufacturers TB Disease Vaccine Product Type
Table 13. Global TB Disease Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of TB Disease Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. TB Disease Vaccine Market Challenges
Table 22. Market Restraints
Table 23. Global TB Disease Vaccine Sales by Type (K MT)
Table 24. Global TB Disease Vaccine Market Size by Type (M USD)
Table 25. Global TB Disease Vaccine Sales (K MT) by Type (2018-2023)
Table 26. Global TB Disease Vaccine Sales Market Share by Type (2018-2023)
Table 27. Global TB Disease Vaccine Market Size (M USD) by Type (2018-2023)
Table 28. Global TB Disease Vaccine Market Size Share by Type (2018-2023)
Table 29. Global TB Disease Vaccine Price (USD/MT) by Type (2018-2023)
Table 30. Global TB Disease Vaccine Sales (K MT) by Application
Table 31. Global TB Disease Vaccine Market Size by Application
Table 32. Global TB Disease Vaccine Sales by Application (2018-2023) & (K MT)
Table 33. Global TB Disease Vaccine Sales Market Share by Application (2018-2023)
Table 34. Global TB Disease Vaccine Sales by Application (2018-2023) & (M USD)
Table 35. Global TB Disease Vaccine Market Share by Application (2018-2023)
Table 36. Global TB Disease Vaccine Sales Growth Rate by Application (2018-2023)
Table 37. Global TB Disease Vaccine Sales by Region (2018-2023) & (K MT)
Table 38. Global TB Disease Vaccine Sales Market Share by Region (2018-2023)
Table 39. North America TB Disease Vaccine Sales by Country (2018-2023) & (K MT)
Table 40. Europe TB Disease Vaccine Sales by Country (2018-2023) & (K MT)
Table 41. Asia Pacific TB Disease Vaccine Sales by Region (2018-2023) & (K MT)
Table 42. South America TB Disease Vaccine Sales by Country (2018-2023) & (K MT)
Table 43. Middle East and Africa TB Disease Vaccine Sales by Region (2018-2023) & (K MT)
Table 44. Merck TB Disease Vaccine Basic Information
Table 45. Merck TB Disease Vaccine Product Overview
Table 46. Merck TB Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 47. Merck Business Overview
Table 48. Merck TB Disease Vaccine SWOT Analysis
Table 49. Merck Recent Developments
Table 50. Japan BCG Lab TB Disease Vaccine Basic Information
Table 51. Japan BCG Lab TB Disease Vaccine Product Overview
Table 52. Japan BCG Lab TB Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 53. Japan BCG Lab Business Overview
Table 54. Japan BCG Lab TB Disease Vaccine SWOT Analysis
Table 55. Japan BCG Lab Recent Developments
Table 56. Serum Institute of India TB Disease Vaccine Basic Information
Table 57. Serum Institute of India TB Disease Vaccine Product Overview
Table 58. Serum Institute of India TB Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 59. Serum Institute of India Business Overview
Table 60. Serum Institute of India TB Disease Vaccine SWOT Analysis
Table 61. Serum Institute of India Recent Developments
Table 62. AJ Vaccines TB Disease Vaccine Basic Information
Table 63. AJ Vaccines TB Disease Vaccine Product Overview
Table 64. AJ Vaccines TB Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 65. AJ Vaccines Business Overview
Table 66. AJ Vaccines TB Disease Vaccine SWOT Analysis
Table 67. AJ Vaccines Recent Developments
Table 68. BioFarma TB Disease Vaccine Basic Information
Table 69. BioFarma TB Disease Vaccine Product Overview
Table 70. BioFarma TB Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 71. BioFarma Business Overview
Table 72. BioFarma TB Disease Vaccine SWOT Analysis
Table 73. BioFarma Recent Developments
Table 74. GreenSignal Bio Pharma TB Disease Vaccine Basic Information
Table 75. GreenSignal Bio Pharma TB Disease Vaccine Product Overview
Table 76. GreenSignal Bio Pharma TB Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 77. GreenSignal Bio Pharma Business Overview
Table 78. GreenSignal Bio Pharma Recent Developments
Table 79. China National Biotec TB Disease Vaccine Basic Information
Table 80. China National Biotec TB Disease Vaccine Product Overview
Table 81. China National Biotec TB Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 82. China National Biotec Business Overview
Table 83. China National Biotec Recent Developments
Table 84. Biomed Lublin TB Disease Vaccine Basic Information
Table 85. Biomed Lublin TB Disease Vaccine Product Overview
Table 86. Biomed Lublin TB Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 87. Biomed Lublin Business Overview
Table 88. Biomed Lublin Recent Developments
Table 89. Taj Pharmaceuticals TB Disease Vaccine Basic Information
Table 90. Taj Pharmaceuticals TB Disease Vaccine Product Overview
Table 91. Taj Pharmaceuticals TB Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 92. Taj Pharmaceuticals Business Overview
Table 93. Taj Pharmaceuticals Recent Developments
Table 94. Ataulpho de Paiva TB Disease Vaccine Basic Information
Table 95. Ataulpho de Paiva TB Disease Vaccine Product Overview
Table 96. Ataulpho de Paiva TB Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 97. Ataulpho de Paiva Business Overview
Table 98. Ataulpho de Paiva Recent Developments
Table 99. IVAC TB Disease Vaccine Basic Information
Table 100. IVAC TB Disease Vaccine Product Overview
Table 101. IVAC TB Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 102. IVAC Business Overview
Table 103. IVAC Recent Developments
Table 104. Queen Saovabha Mem. Inst TB Disease Vaccine Basic Information
Table 105. Queen Saovabha Mem. Inst TB Disease Vaccine Product Overview
Table 106. Queen Saovabha Mem. Inst TB Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 107. Queen Saovabha Mem. Inst Business Overview
Table 108. Queen Saovabha Mem. Inst Recent Developments
Table 109. Microgen TB Disease Vaccine Basic Information
Table 110. Microgen TB Disease Vaccine Product Overview
Table 111. Microgen TB Disease Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 112. Microgen Business Overview
Table 113. Microgen Recent Developments
Table 114. Global TB Disease Vaccine Sales Forecast by Region (2024-2029) & (K MT)
Table 115. Global TB Disease Vaccine Market Size Forecast by Region (2024-2029) & (M USD)
Table 116. North America TB Disease Vaccine Sales Forecast by Country (2024-2029) & (K MT)
Table 117. North America TB Disease Vaccine Market Size Forecast by Country (2024-2029) & (M USD)
Table 118. Europe TB Disease Vaccine Sales Forecast by Country (2024-2029) & (K MT)
Table 119. Europe TB Disease Vaccine Market Size Forecast by Country (2024-2029) & (M USD)
Table 120. Asia Pacific TB Disease Vaccine Sales Forecast by Region (2024-2029) & (K MT)
Table 121. Asia Pacific TB Disease Vaccine Market Size Forecast by Region (2024-2029) & (M USD)
Table 122. South America TB Disease Vaccine Sales Forecast by Country (2024-2029) & (K MT)
Table 123. South America TB Disease Vaccine Market Size Forecast by Country (2024-2029) & (M USD)
Table 124. Middle East and Africa TB Disease Vaccine Consumption Forecast by Country (2024-2029) & (Units)
Table 125. Middle East and Africa TB Disease Vaccine Market Size Forecast by Country (2024-2029) & (M USD)
Table 126. Global TB Disease Vaccine Sales Forecast by Type (2024-2029) & (K MT)
Table 127. Global TB Disease Vaccine Market Size Forecast by Type (2024-2029) & (M USD)
Table 128. Global TB Disease Vaccine Price Forecast by Type (2024-2029) & (USD/MT)
Table 129. Global TB Disease Vaccine Sales (K MT) Forecast by Application (2024-2029)
Table 130. Global TB Disease Vaccine Market Size Forecast by Application (2024-2029) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of TB Disease Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global TB Disease Vaccine Market Size (M USD), 2018-2029
Figure 5. Global TB Disease Vaccine Market Size (M USD) (2018-2029)
Figure 6. Global TB Disease Vaccine Sales (K MT) & (2018-2029)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. TB Disease Vaccine Market Size by Country (M USD)
Figure 11. TB Disease Vaccine Sales Share by Manufacturers in 2022
Figure 12. Global TB Disease Vaccine Revenue Share by Manufacturers in 2022
Figure 13. TB Disease Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 Vs 2022
Figure 14. Global Market TB Disease Vaccine Average Price (USD/MT) of Key Manufacturers in 2022
Figure 15. The Global 5 and 10 Largest Players: Market Share by TB Disease Vaccine Revenue in 2022
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global TB Disease Vaccine Market Share by Type
Figure 18. Sales Market Share of TB Disease Vaccine by Type (2018-2023)
Figure 19. Sales Market Share of TB Disease Vaccine by Type in 2022
Figure 20. Market Size Share of TB Disease Vaccine by Type (2018-2023)
Figure 21. Market Size Market Share of TB Disease Vaccine by Type in 2022
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global TB Disease Vaccine Market Share by Application
Figure 24. Global TB Disease Vaccine Sales Market Share by Application (2018-2023)
Figure 25. Global TB Disease Vaccine Sales Market Share by Application in 2022
Figure 26. Global TB Disease Vaccine Market Share by Application (2018-2023)
Figure 27. Global TB Disease Vaccine Market Share by Application in 2022
Figure 28. Global TB Disease Vaccine Sales Growth Rate by Application (2018-2023)
Figure 29. Global TB Disease Vaccine Sales Market Share by Region (2018-2023)
Figure 30. North America TB Disease Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 31. North America TB Disease Vaccine Sales Market Share by Country in 2022
Figure 32. U.S. TB Disease Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 33. Canada TB Disease Vaccine Sales (K MT) and Growth Rate (2018-2023)
Figure 34. Mexico TB Disease Vaccine Sales (Units) and Growth Rate (2018-2023)
Figure 35. Europe TB Disease Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 36. Europe TB Disease Vaccine Sales Market Share by Country in 2022
Figure 37. Germany TB Disease Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 38. France TB Disease Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 39. U.K. TB Disease Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 40. Italy TB Disease Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 41. Russia TB Disease Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 42. Asia Pacific TB Disease Vaccine Sales and Growth Rate (K MT)
Figure 43. Asia Pacific TB Disease Vaccine Sales Market Share by Region in 2022
Figure 44. China TB Disease Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 45. Japan TB Disease Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 46. South Korea TB Disease Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 47. India TB Disease Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 48. Southeast Asia TB Disease Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 49. South America TB Disease Vaccine Sales and Growth Rate (K MT)
Figure 50. South America TB Disease Vaccine Sales Market Share by Country in 2022
Figure 51. Brazil TB Disease Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 52. Argentina TB Disease Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 53. Columbia TB Disease Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 54. Middle East and Africa TB Disease Vaccine Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa TB Disease Vaccine Sales Market Share by Region in 2022
Figure 56. Saudi Arabia TB Disease Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 57. UAE TB Disease Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 58. Egypt TB Disease Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 59. Nigeria TB Disease Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 60. South Africa TB Disease Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 61. Global TB Disease Vaccine Sales Forecast by Volume (2018-2029) & (K MT)
Figure 62. Global TB Disease Vaccine Market Size Forecast by Value (2018-2029) & (M USD)
Figure 63. Global TB Disease Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 64. Global TB Disease Vaccine Market Share Forecast by Type (2024-2029)
Figure 65. Global TB Disease Vaccine Sales Forecast by Application (2024-2029)
Figure 66. Global TB Disease Vaccine Market Share Forecast by Application (2024-2029)
Figure 1. Product Picture of TB Disease Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global TB Disease Vaccine Market Size (M USD), 2018-2029
Figure 5. Global TB Disease Vaccine Market Size (M USD) (2018-2029)
Figure 6. Global TB Disease Vaccine Sales (K MT) & (2018-2029)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. TB Disease Vaccine Market Size by Country (M USD)
Figure 11. TB Disease Vaccine Sales Share by Manufacturers in 2022
Figure 12. Global TB Disease Vaccine Revenue Share by Manufacturers in 2022
Figure 13. TB Disease Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 Vs 2022
Figure 14. Global Market TB Disease Vaccine Average Price (USD/MT) of Key Manufacturers in 2022
Figure 15. The Global 5 and 10 Largest Players: Market Share by TB Disease Vaccine Revenue in 2022
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global TB Disease Vaccine Market Share by Type
Figure 18. Sales Market Share of TB Disease Vaccine by Type (2018-2023)
Figure 19. Sales Market Share of TB Disease Vaccine by Type in 2022
Figure 20. Market Size Share of TB Disease Vaccine by Type (2018-2023)
Figure 21. Market Size Market Share of TB Disease Vaccine by Type in 2022
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global TB Disease Vaccine Market Share by Application
Figure 24. Global TB Disease Vaccine Sales Market Share by Application (2018-2023)
Figure 25. Global TB Disease Vaccine Sales Market Share by Application in 2022
Figure 26. Global TB Disease Vaccine Market Share by Application (2018-2023)
Figure 27. Global TB Disease Vaccine Market Share by Application in 2022
Figure 28. Global TB Disease Vaccine Sales Growth Rate by Application (2018-2023)
Figure 29. Global TB Disease Vaccine Sales Market Share by Region (2018-2023)
Figure 30. North America TB Disease Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 31. North America TB Disease Vaccine Sales Market Share by Country in 2022
Figure 32. U.S. TB Disease Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 33. Canada TB Disease Vaccine Sales (K MT) and Growth Rate (2018-2023)
Figure 34. Mexico TB Disease Vaccine Sales (Units) and Growth Rate (2018-2023)
Figure 35. Europe TB Disease Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 36. Europe TB Disease Vaccine Sales Market Share by Country in 2022
Figure 37. Germany TB Disease Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 38. France TB Disease Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 39. U.K. TB Disease Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 40. Italy TB Disease Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 41. Russia TB Disease Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 42. Asia Pacific TB Disease Vaccine Sales and Growth Rate (K MT)
Figure 43. Asia Pacific TB Disease Vaccine Sales Market Share by Region in 2022
Figure 44. China TB Disease Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 45. Japan TB Disease Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 46. South Korea TB Disease Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 47. India TB Disease Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 48. Southeast Asia TB Disease Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 49. South America TB Disease Vaccine Sales and Growth Rate (K MT)
Figure 50. South America TB Disease Vaccine Sales Market Share by Country in 2022
Figure 51. Brazil TB Disease Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 52. Argentina TB Disease Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 53. Columbia TB Disease Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 54. Middle East and Africa TB Disease Vaccine Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa TB Disease Vaccine Sales Market Share by Region in 2022
Figure 56. Saudi Arabia TB Disease Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 57. UAE TB Disease Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 58. Egypt TB Disease Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 59. Nigeria TB Disease Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 60. South Africa TB Disease Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 61. Global TB Disease Vaccine Sales Forecast by Volume (2018-2029) & (K MT)
Figure 62. Global TB Disease Vaccine Market Size Forecast by Value (2018-2029) & (M USD)
Figure 63. Global TB Disease Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 64. Global TB Disease Vaccine Market Share Forecast by Type (2024-2029)
Figure 65. Global TB Disease Vaccine Sales Forecast by Application (2024-2029)
Figure 66. Global TB Disease Vaccine Market Share Forecast by Application (2024-2029)
